Abiraterone and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Post Chemotherapy- An Indirect Comparison and Budget Impact Analysis
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.412
https://www.valueinhealthjournal.com/article/S1098-3015(13)02317-6/fulltext
Title :
Abiraterone and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Post Chemotherapy- An Indirect Comparison and Budget Impact Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02317-6&doi=10.1016/j.jval.2013.08.412
First page :
A394
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
396